|Articles|July 20, 2012
Keith Dunleavy, MD, Speaks About Health and Data Research
Keith Dunleavy, MD, President and CEO, Inovalon, discusses the importance of comparative effectiveness research in order to improve chronic disease management at both the individual and population levels.
Advertisement
Keith Dunleavy, MD, President and CEO, Inovalon, discusses the importance of comparative effectiveness research in order to improve chronic disease management at both the individual and population levels. Dr. Dunleavy also addresses decision support through target interventions.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
3
Sarcoma Gene Signature May Predict Who Benefits From Pazopanib
4
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
5